Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: Pender Assisted Therapy (PATh) - Prospective Study of the Treatment of HCV
Completed prospective clinical trial evaluating Pender Assisted Therapy (PATh) for treating hepatitis C.
-
CLINICAL_TRIALS trial_result · 2009-10-07Clinical Trial Update: Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection [Phase 1]
A Phase 1 clinical trial evaluating PEG-rIL-29 (PEG-IFN lambda) in adults with chronic hepatitis C virus infection has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-24Clinical Trial Update: A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection. [Phase 1, Phase 2]
A proof-of-concept study of VCH-759 for chronic hepatitis C infection in Phase 1 and Phase 2 has been completed.
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients [Phase 2]
Phase 2 study evaluating antiviral activity and safety of three different doses of mifepristone in hepatitis C patients; results were posted…
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: Blood Antioxidant Status in Chronic Hepatitis C Patients Before and After Antioxidant Supplementation: a Randomized Clinical Trial [NA]
A completed randomized clinical trial evaluating the effect of antioxidant supplementation on blood antioxidant status in patients with chro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: Safety Study of SPC3649 in Healthy Men [Phase 1]
Phase 1 safety study of SPC3649 in healthy men has completed. The trial, sponsored by Santaris Pharma A/S, pertained to Hepatitis C.
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis C
Update on a clinical trial investigating noninvasive methods to evaluate hepatic fibrosis in chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2009-09-17Clinical Trial Update: Pegasys® Plus Ribavirin in Hemophilic Patients With Hepatitis C Virus Infection [Phase 4]
A Phase 4 trial evaluating Pegasys (pegylated interferon alfa-2a) plus ribavirin in hemophilic patients with hepatitis C has completed. The …
-
CLINICAL_TRIALS trial_result · 2009-09-16Clinical Trial Update: Study the Safety and Effectiveness of MK7009 in Hepatitis C Infected Patients (MK-7009-004)(COMPLETED) [Phase 1]
The Phase 1 study MK-7009-004 evaluating MK-7009 in hepatitis C patients has completed and results were posted in September 2009.
-
CLINICAL_TRIALS trial_result · 2009-09-07Clinical Trial Update: Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients [Phase 4]
A Phase 4 randomized trial compares 24-week versus 48-week treatment with peginterferon alfa-2a plus ribavirin in patients with hepatitis C …
-
CLINICAL_TRIALS trial_result · 2009-09-07Clinical Trial Update: Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies [Phase 4]
This clinical trial update describes a Phase 4 pilot study of patients with chronic hepatitis C co-infected with HIV who relapsed after prio…
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment [Phase 3]
Phase 3 trial evaluating long-term interferon for patients with hepatitis C who did not clear the virus with standard treatment; study compl…
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)
A completed clinical trial assessing compliance of genotype 1 hepatitis C patients treated with PegIntron and Rebetol under a patient-assist…
-
CLINICAL_TRIALS trial_result · 2009-08-13Clinical Trial Update: Alcohol Use Reduction in Methadone Individuals With Hepatitis C Virus(HCV) [Phase 2]
Phase 2 clinical trial evaluating interventions to reduce alcohol use in individuals on methadone with hepatitis C; status: completed.
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548) [Phase 3]
Phase 3 trial evaluating three regimens of PegIntron (pegylated interferon alfa-2b) plus ribavirin in treatment-naïve adults with chronic he…
-
CLINICAL_TRIALS research · 2009-08-11Clinical Trial Update: PEG-IFN Plus Ribavirin Combination Therapy for Older Patients [NA]
A clinical trial update examining PEG-IFN plus ribavirin for older patients with hepatitis C, with the current status of the study reported …
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: Zidovudine Levels in HIV Infected Patients Being Treated for HCV [Phase 1, Phase 2]
This clinical trial update reports on zidovudine concentration levels in HIV-infected patients treated for hepatitis C in Phase 1 and Phase …
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: NIDDM and IR in Combination Therapy for CHC [NA]
Update on a combination therapy trial for chronic hepatitis C focusing on insulin resistance and non-insulin-dependent diabetes mellitus; th…
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067)
This is a completed clinical trial (Study P04067) evaluating patient satisfaction in chronic hepatitis C patients treated with PegIntron and…
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: The Effects of PegIntron Plus Rebetol in Subjects With Chronic Hepatitis C Not Responding to Pegasys (Study P03833) [Phase 3]
Phase 3 trial P03833 evaluating PegIntron (peginterferon alfa-2b) plus Rebetol (ribavirin) in chronic hepatitis C patients who did not respo…
-
CLINICAL_TRIALS trial_result · 2009-07-23Clinical Trial Update: Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED) [Phase 4]
A Phase 4 study comparing 48 weeks versus 24 weeks of Peg-Intron with ribavirin in chronic hepatitis C (genotype 3) was terminated; results …
-
CLINICAL_TRIALS trial_result · 2009-07-17Clinical Trial Update: Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED)
A completed clinical trial evaluating patient satisfaction with PegIntron Pen plus Rebetol in chronic hepatitis C patients.
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: Extended Treatment With PEG-Intron® and Rebetol® in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685) [Phase 3]
A Phase 3 study evaluating extended treatment with PEG-Intron and Rebetol in genotype 1 chronic hepatitis C patients with slow virologic res…
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: Bioavailability Study Of PF-00868554 Administered As 3x250mg Oral Tablets (Wet Granulate, 3x250mg Oral Tablets (Dry Granulate) And 750mg Solution Under Fed State [Phase 1]
Phase 1 bioavailability study of PF-00868554 administered as 3x250 mg tablets (wet granulate), 3x250 mg tablets (dry granulate), and a 750 m…
-
CLINICAL_TRIALS trial_result · 2009-07-03Clinical Trial Update: CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders) [Phase 2]
This is a Phase 2 clinical trial update reporting the completion of a study evaluating CIFN and interferon gamma-1b, with or without ribavir…